Merck to buy biotech firm EyeBio for up to $3B

Merck & Co. Inc. announced on Wednesday that it will acquire all outstanding shares of Eyebiotech Ltd. (EyeBio) for up to $3 billion, including an upfront payment of $1.3 billion in cash and a fur…